IL118188A - Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drug - Google Patents
Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drugInfo
- Publication number
- IL118188A IL118188A IL11818896A IL11818896A IL118188A IL 118188 A IL118188 A IL 118188A IL 11818896 A IL11818896 A IL 11818896A IL 11818896 A IL11818896 A IL 11818896A IL 118188 A IL118188 A IL 118188A
- Authority
- IL
- Israel
- Prior art keywords
- plasma
- assured
- quality
- drug
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2496/00—Reference solutions for assays of biological material
- G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
The invention relates to a medicament containing one or more plasma derivatives as the active or auxiliary agent, in which the basic material or the intermediate products arising during the production of the plasma derivatives exert no viral stress on one or more differently proliferable haematogenic viruses or such an effect not exceeding a defined limit. The basic material or intermediate product for producing the final plasma derivative of which the quality is thus assured is subsequently subjected to at least one essential viral enrichment or inactivation step. The invention also describes a process for producing the medicament and the production of assured-quality basic materials or intermediate products.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0077895A AT406019B (en) | 1995-05-08 | 1995-05-08 | METHOD FOR PRODUCING A MEDICINAL PRODUCT CONTAINING ONE OR MORE PLASMA DERIVATIVES |
Publications (2)
Publication Number | Publication Date |
---|---|
IL118188A0 IL118188A0 (en) | 1996-09-12 |
IL118188A true IL118188A (en) | 2000-07-16 |
Family
ID=3499516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11818896A IL118188A (en) | 1995-05-08 | 1996-05-08 | Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drug |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0769954B2 (en) |
JP (2) | JPH10502943A (en) |
AT (2) | AT406019B (en) |
CA (1) | CA2191475C (en) |
DE (1) | DE59610626D1 (en) |
DK (1) | DK0769954T4 (en) |
ES (1) | ES2203688T5 (en) |
IL (1) | IL118188A (en) |
NO (1) | NO322186B1 (en) |
WO (1) | WO1996035437A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5780222A (en) | 1995-04-10 | 1998-07-14 | Alpha Therapeutic Corporation | Method of PCR testing of pooled blood samples |
AT403477B (en) * | 1996-04-30 | 1998-02-25 | Immuno Ag | BIOLOGICAL MATERIAL FREE OF VIRAL AND MOLECULAR PATHOGENES AND METHOD FOR THE PRODUCTION THEREOF |
AU741141B2 (en) * | 1997-11-04 | 2001-11-22 | Roche Diagnostics Gmbh | Specific and sensitive method for detecting nucleic acids |
DE19752898A1 (en) * | 1997-11-28 | 1999-08-05 | Centeon Pharma Gmbh | Method for the detection of high concentrations of four in blood plasma and / or blood serum by means of the polymerase chain reaction |
AT407160B (en) * | 1998-06-04 | 2001-01-25 | Immuno Ag | METHOD FOR DETERMINING ANTIGENS |
AU774118B2 (en) | 1999-02-12 | 2004-06-17 | Baxter Healthcare Sa | A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method |
AT410218B (en) | 1999-08-20 | 2003-03-25 | Baxter Ag | METHOD FOR PRODUCING A QUALITY-ASSURED POOL OF BIOLOGICAL SAMPLES |
PL1711513T3 (en) * | 2003-12-01 | 2014-12-31 | Novo Nordisk Healthcare Ag | Nanofiltration of factor vii solutions to remove virus |
DE102005054206B4 (en) * | 2005-11-14 | 2010-07-15 | Roth, Willi, Prof. Dr. | Method and apparatus for automated processing of pooled samples |
AU2016315836A1 (en) * | 2015-09-02 | 2018-02-15 | Ep Minerals, Llc | Regenerated media useful in the treatment of fermented liquids |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0447984A1 (en) * | 1990-03-20 | 1991-09-25 | Abbott Laboratories | Hyperimmune globulin against hepatitis C virus and method for making same |
WO1992001714A1 (en) † | 1990-07-24 | 1992-02-06 | Yamanouchi Pharmaceutical Co., Ltd. | Non-a non-b hepatitis virus antigen |
JP3114731B2 (en) * | 1990-08-14 | 2000-12-04 | 国立感染症研究所長 | Peptide antigen for detecting hepatitis C virus antibody and method of using the same |
JPH04300000A (en) * | 1991-03-27 | 1992-10-23 | Teijin Ltd | Method for determining nucleic acid |
AT402891B (en) * | 1991-06-20 | 1997-09-25 | Immuno Ag | METHOD FOR PRODUCING AN INACTIVATED BLOOD PRODUCT |
AU4248193A (en) † | 1992-05-15 | 1993-12-13 | New England Deaconess Hospital | Quantitation of viral rna by competitive polymerase chain reaction |
EP0586112A3 (en) * | 1992-08-14 | 1994-09-14 | Pharma Gen S A | Control of pcr mediated detection of micro-organisms |
DK0590327T3 (en) * | 1992-09-11 | 2003-07-28 | Hoffmann La Roche | Detection of nucleic acids in blood |
CA2159044A1 (en) * | 1994-09-26 | 1996-03-27 | Falko-Guenter Falkner | Method of quantitating nucleic acids |
-
1995
- 1995-05-08 AT AT0077895A patent/AT406019B/en not_active IP Right Cessation
-
1996
- 1996-05-06 JP JP8533598A patent/JPH10502943A/en active Pending
- 1996-05-06 AT AT96910855T patent/ATE245989T1/en active
- 1996-05-06 DE DE59610626T patent/DE59610626D1/en not_active Expired - Lifetime
- 1996-05-06 CA CA2191475A patent/CA2191475C/en not_active Expired - Lifetime
- 1996-05-06 ES ES96910855T patent/ES2203688T5/en not_active Expired - Lifetime
- 1996-05-06 EP EP96910855A patent/EP0769954B2/en not_active Expired - Lifetime
- 1996-05-06 DK DK96910855.4T patent/DK0769954T4/en active
- 1996-05-06 WO PCT/AT1996/000089 patent/WO1996035437A1/en active IP Right Grant
- 1996-05-08 IL IL11818896A patent/IL118188A/en not_active IP Right Cessation
-
1997
- 1997-01-07 NO NO19970050A patent/NO322186B1/en not_active IP Right Cessation
-
2008
- 2008-04-22 JP JP2008111565A patent/JP2008247913A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DE59610626D1 (en) | 2003-09-04 |
ES2203688T5 (en) | 2011-07-01 |
DK0769954T4 (en) | 2011-04-04 |
CA2191475C (en) | 2010-09-14 |
EP0769954A1 (en) | 1997-05-02 |
JP2008247913A (en) | 2008-10-16 |
EP0769954B2 (en) | 2011-03-09 |
ES2203688T3 (en) | 2004-04-16 |
NO322186B1 (en) | 2006-08-28 |
CA2191475A1 (en) | 1996-11-14 |
ATE245989T1 (en) | 2003-08-15 |
ATA77895A (en) | 1999-06-15 |
NO970050L (en) | 1997-01-07 |
JPH10502943A (en) | 1998-03-17 |
DK0769954T3 (en) | 2003-11-17 |
NO970050D0 (en) | 1997-01-07 |
IL118188A0 (en) | 1996-09-12 |
EP0769954B1 (en) | 2003-07-30 |
WO1996035437A1 (en) | 1996-11-14 |
AT406019B (en) | 2000-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9900822A3 (en) | Piperazine derivatives, process for producing them, pharmaceutical compositions containing them and method for treating tachykinin-mediated diseases | |
AU6635990A (en) | Process involving sterilization step, product having bacteriocidal activity and process for preparing the same, fumigant, fumigation method, and bacteriocidal gas composition, and process and apparatus for preparing the same | |
ZA966751B (en) | Novel acyl derivatives of melatonin and of metalotoninergic analogues; process for their preparation and their use as medicinal products. | |
HUP9602511A2 (en) | Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these | |
HU9402238D0 (en) | 1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, process for producing them and pharmaceutical compositions containing them | |
IL118188A (en) | Drug containing one or more plasma derivatives a quality-assured plasma starting material for the same and a method for the preparation of the drug | |
HUT49113A (en) | Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components | |
IL117091A0 (en) | Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof | |
HU9402292D0 (en) | New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component | |
NO971323L (en) | Process for the preparation of starch degradation product | |
HUT50775A (en) | Process for producing disubstituted pyridine derivatives and pharmaceutical compositions containing them as active components | |
HUP9602640A3 (en) | Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds. | |
ATE137237T1 (en) | R-(-)-1-(5-HYDROXYHEXYL)-3-METHYL-7-PROPYLXANTHINE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THIS COMPOUND | |
EE9600109A (en) | mixtures and dipeptides containing α-amino and cyclopentane-β-amino acid (s) and / or their derivatives, process for the preparation of dipeptides and medicinal products containing said mixtures and / or dipeptides | |
UA29395C2 (en) | Derivative of pregna-4,9(11),17(20)-trien-3-on, a process for preparation thereof, a process for preparation of 21-acyloxypregna-4,9(11),16-trien-3,20-dion and intermediary compounds | |
HUT58282A (en) | Process for producing new, cyclic ketone derivatives and pharmaceutical compositions containing them as active components | |
AU565799B2 (en) | 4-oxothiazolidin-2-ylidene-acetamide derivatives | |
HUT64548A (en) | Method for producing new phosphocipid derivatives and pharmaceutical preparatives containing them | |
HU9401914D0 (en) | Piperidine- and piperazine derivatives, pharmaceutical compositions containing them as active components and process for producing both | |
HUT69695A (en) | Method for producing indole derivatives | |
AU7808394A (en) | Novel dihispidine derivatives, process for producing them and medicaments containing these compounds | |
HU9500939D0 (en) | New benzimidazol-2-yl derivatives, process for producing them and pharmaceutical compositions containing them | |
JO1822B1 (en) | A novel compound form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |